92 related articles for article (PubMed ID: 28862222)
1. Efficiency of combined blocking of aerobic and glycolytic metabolism pathways in treatment of N1-S1 hepatocellular carcinoma in a rat model.
Yarmohammadi H; Wilkins LR; Erinjeri JP; Novak RD; Exner AA; Wu H; Petre EN; Boas E; Ziv E; Haaga JR
J Cancer Res Ther; 2017; 13(3):533-537. PubMed ID: 28862222
[TBL] [Abstract][Full Text] [Related]
2. Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model.
Gupta S; Kobayashi S; Phongkitkarun S; Broemeling LD; Kan Z
Invest Radiol; 2006 Jun; 41(6):516-21. PubMed ID: 16763470
[TBL] [Abstract][Full Text] [Related]
3. Cinnamic Acid Derivatives Enhance the Efficacy of Transarterial Embolization in a Rat Model of Hepatocellular Carcinoma.
Wilkins LR; Brautigan DL; Wu H; Yarmohammadi H; Kubicka E; Serbulea V; Leitinger N; Liu W; Haaga JR
Cardiovasc Intervent Radiol; 2017 Mar; 40(3):430-437. PubMed ID: 27872984
[TBL] [Abstract][Full Text] [Related]
4. Increased metastatic potential of residual carcinoma after transarterial embolization in rat with McA-RH7777 hepatoma.
Wang GZ; Fang ZT; Zhang W; Qu XD; Qian S; Liu R; Wang JH
Oncol Rep; 2014 Jan; 31(1):95-102. PubMed ID: 24173823
[TBL] [Abstract][Full Text] [Related]
5. Transarterial Embolization for Hepatocellular Carcinoma: A Comparison between Nonspherical PVA and Microspheres.
Scaffaro LA; Kruel CD; Stella SF; Gravina GL; Machado Filho G; Borges de Almeida CP; Pinto LC; Alvares-da-Silva MR; Kruel CR
Biomed Res Int; 2015; 2015():435120. PubMed ID: 26413523
[TBL] [Abstract][Full Text] [Related]
6. [Intra-arterial chemotherapy for the treatment of advanced hepatocellular carcinoma through implantable port (reservoir)].
Motohara T; Ozawa Z; Morita S
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2645-8. PubMed ID: 7979426
[TBL] [Abstract][Full Text] [Related]
7. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model.
Qian J; Oppermann E; Tran A; Imlau U; Qian K; Vogl TJ
World J Gastroenterol; 2016 Jun; 22(21):5042-9. PubMed ID: 27275096
[TBL] [Abstract][Full Text] [Related]
8. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
[TBL] [Abstract][Full Text] [Related]
9. Transarterial Chemoembolization Using Sorafenib in a Rabbit VX2 Liver Tumor Model: Pharmacokinetics and Antitumor Effect.
Kim GM; Kim MD; Kim do Y; Kim SH; Won JY; Park SI; Lee do Y; Shin W; Shin M
J Vasc Interv Radiol; 2016 Jul; 27(7):1086-92. PubMed ID: 27179404
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular necrosis, apoptosis, and proliferation after transcatheter arterial embolization or chemoembolization in a standardized rabbit model.
Wang Y; Zheng C; Liang B; Zhao H; Qian J; Liang H; Feng G
J Vasc Interv Radiol; 2011 Nov; 22(11):1606-12. PubMed ID: 21959058
[TBL] [Abstract][Full Text] [Related]
11. Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization.
Braren R; Altomonte J; Settles M; Neff F; Esposito I; Ebert O; Schwaiger M; Rummeny E; Steingoetter A
J Hepatol; 2011 Nov; 55(5):1034-40. PubMed ID: 21354233
[TBL] [Abstract][Full Text] [Related]
12. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings.
Matsuo N; Uchida H; Sakaguchi H; Nishimine K; Nishimura Y; Hirohashi S; Ohishi H
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-61-S6-70. PubMed ID: 9151919
[TBL] [Abstract][Full Text] [Related]
13. Sprague-Dawley rats bearing McA-RH7777 cells for study of hepatoma and transarterial chemoembolization.
Cho HR; Choi JW; Kim HC; Song YS; Kim GM; Son KR; Chung JW
Anticancer Res; 2013 Jan; 33(1):223-30. PubMed ID: 23267149
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation combined with transcatheter therapy in rabbit VX2 liver tumors: effects and histopathological characteristics.
Duan X; Zhou G; Han X; Ren J; Zheng C; Liang H; Feng G
Acta Radiol; 2015 Jan; 56(1):87-96. PubMed ID: 24425792
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic therapy enhances the efficacy of transcatheter arterial embolization for hepatocellular carcinomas.
Jiang H; Meng Q; Tan H; Pan S; Sun B; Xu R; Sun X
Int J Cancer; 2007 Jul; 121(2):416-24. PubMed ID: 17330237
[TBL] [Abstract][Full Text] [Related]
16. Transarterial embolization combined with RNA interference targeting hypoxia-inducible factor-1α for hepatocellular carcinoma: a preliminary study of rat model.
Ni JY; Xu LF; Wang WD; Huang QS; Sun HL; Chen YT
J Cancer Res Clin Oncol; 2017 Feb; 143(2):199-207. PubMed ID: 27638772
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma.
Qu K; Yan Z; Wu Y; Chen Y; Qu P; Xu X; Yuan P; Huang X; Xing J; Zhang H; Liu C; Zhang J
J Gastroenterol Hepatol; 2015 May; 30(5):925-32. PubMed ID: 25641377
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization.
Tanaka K; Nakamura S; Numata K; Okazaki H; Endo O; Inoue S; Takamura Y; Sugiyama M; Ohaki Y
Radiology; 1992 Nov; 185(2):457-60. PubMed ID: 1329143
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol.
Vogl TJ; Oppermann E; Qian J; Imlau U; Tran A; Hamidavi Y; Korkusuz H; Bechstein WO; Nour-Eldin NE; Gruber-Rouh T; Hammerstingl R; Naguib NN
BMC Cancer; 2016 May; 16():325. PubMed ID: 27215551
[TBL] [Abstract][Full Text] [Related]
20. Pilot Evaluation of Angiogenesis Signaling Factor Response after Transcatheter Arterial Embolization for Hepatocellular Carcinoma.
Ronald J; Nixon AB; Marin D; Gupta RT; Janas G; Chen W; Suhocki PV; Pabon-Ramos W; Sopko DR; Starr MD; Brady JC; Hurwitz HI; Kim CY
Radiology; 2017 Oct; 285(1):311-318. PubMed ID: 28787261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
